Serebruany, Victor L.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: The PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) Trial

Victor L. Serebruany, Alex I. Malinin, Alex Pokov, Gregory Barsness, Dan F. Hanley

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 172 KB

english, 2008

2

Effect of Aliskiren and Valsartan Combination Versus Aliskiren Monotherapy on Hemostatic Biomarkers in Hypertensive Diabetics

Serebruany, Victor L., Pokov, Alex N., Aradi, Daniel, Can, Mehmet, DiNicolantonio, James, Kipshidze, Nodar, Atar, Dan

Journal:

American Journal of Therapeutics

Year:

2014

Language:

english

File:

PDF, 129 KB

english, 2014

3

Dyspnea and Reversibility of Antiplatelet Agents: Ticagrelor, Elinogrel, Cangrelor, and Beyond

Serebruany, Victor L., Sibbing, Dirk, DiNicolantonio, James J.

Journal:

Year:

2014

Language:

english

File:

PDF, 114 KB

english, 2014

4

Statin Wars: The Heavyweight Match-Atorvastatin versus Rosuvastatin for the Treatment of Atherosclerosis, Heart Failure, and Chronic Kidney Disease

DiNicolantonio, James J., Lavie, Carl J., Serebruany, Victor L., O'Keefe, James H.

Journal:

Postgraduate Medicine

Year:

2013

Language:

english

File:

PDF, 433 KB

english, 2013

5

Inferiority of ticagrelor in the PHILO trial: Play of chance in East Asians or nightmare confirmation of PLATO-USA?

Serebruany, Victor L., Tomek, Ales, Pya, Yury, Bekbossynova, Makhabbat, Kim, Moo Hyun

Journal:

International Journal of Cardiology

Year:

2016

Language:

english

File:

PDF, 201 KB

english, 2016

6

Ranolazine, ACE Inhibitors, and Angiotensin Receptor Blockers

Marciniak, Thomas A., Serebruany, Victor

Journal:

The American Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 705 KB

english, 2019

7

Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?

Marciniak, Thomas A., Atar, Dan, Serebruany, Victor

Journal:

The American Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 1.20 MB

english, 2019

8

Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Serebruany, Victor, Tanguay, Jean-Francois, Benavides, Mario Alberto, Cabrera-Fuentes, Hector, Eisert, Wolfgang, Kim, Moo Hyun, Yoon, Junghan, Lee, Cheol-Whan, Jang, Kiyuk, Swan, James, Marciniak, Tho

Journal:

American Journal of Therapeutics

Year:

2020

File:

PDF, 386 KB

2020

9

Plasma fibronectin during myocardial ischemia-reperfusion: Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor

Serebruany, Victor L., Solomon, Scott R., Herzog, William R., Gurbel, Paul A.

Journal:

American Journal of Hematology

Year:

1998

Language:

english

File:

PDF, 36 KB

english, 1998

10

Rapid platelet inhibition after a single capsule of Aggrenox®: Challenging a conventional full-dose aspirin antiplatelet advantage?

Victor L. Serebruany, Alex I. Malinin, David C. Sane

Journal:

American Journal of Hematology

Year:

2003

Language:

english

File:

PDF, 43 KB

english, 2003

11

Risk of bleeding complications with antiplatelet agents: Meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials

Victor L. Serebruany, Alex I. Malinin, Roswith M. Eisert, David C. Sane

Journal:

American Journal of Hematology

Year:

2004

Language:

english

File:

PDF, 92 KB

english, 2004

12

Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction

Victor Serebruany

Journal:

Evidence-based Healthcare

Year:

2004

Language:

english

File:

PDF, 131 KB

english, 2004

13

Effects of in vitro exposure of alcohol on surface receptor expression of human platelets

Marcus E. McKenzie, Christopher R. Bell, Eric D. Horowitz, Benjamin R. Oshrine, Dan Atar, Victor L. Serebruany

Journal:

Clinical Physiology and Functional Imaging

Year:

2002

Language:

english

File:

PDF, 58 KB

english, 2002

14

Hypoproteinemia in the hemolytic-uremic syndrome of childhood

Victor L. Serebruany, Marie J. Christenson, John Pescetti, Robert H. McLean

Journal:

Pediatric Nephrology

Year:

1993

Language:

english

File:

PDF, 237 KB

english, 1993

15

Regional and systemic platelet function is altered by myocardial ischemia-reperfusion

Paul A. Gurbel, Victor L. Serebruany, Steven F. Komjathy, Maureen E. Collins, David C. Sane, Helen J. Scott, Matthew L. Schlossberg, William R. Herzog

Journal:

Journal of Thrombosis and Thrombolysis

Year:

1995

Language:

english

File:

PDF, 1.16 MB

english, 1995

16

Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine

William R. Herzog, Paul A. Gurbel, Robert A. Vogel, Matthew L. Schlossberg, Alan I. Schneider, Victor L. Serebruany

Journal:

Journal of Thrombosis and Thrombolysis

Year:

1995

Language:

english

File:

PDF, 1.16 MB

english, 1995

17

NPC 15669, an antiinflammatory leucine derivative, reduces in vitro platelet aggregability in both swine and human plasma

Victor L. Serebruany, William R. Herzog, Paul A. Gurbel, Matthew L. Schlossberg, Helen J. Scott, Robert A. Vogel

Journal:

Journal of Thrombosis and Thrombolysis

Year:

1995

Language:

english

File:

PDF, 765 KB

english, 1995

18

Decreased intraplatelet Ca2+release and ATP secretion in pediatric nephrotic syndrome

S. I. Svetlov, Elena S. Moskaleva, Vsevolod G. Pinelis, Yevgeny Daikhin, Victor L. Serebruany

Journal:

Pediatric Nephrology

Year:

1999

Language:

english

File:

PDF, 43 KB

english, 1999

19

Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease

Victor L. Serebruany, Alex Malinin, Stephen Ong, Dan Atar

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2008

Language:

english

File:

PDF, 161 KB

english, 2008

20

Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study

Louis T. van Zyl, Francois Lespérance, Nancy Frasure-Smith, Alex I. Malinin, Dan Atar, Marc-André Laliberté, Victor L. Serebruany

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2009

Language:

english

File:

PDF, 195 KB

english, 2009

21

Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy

Victor Serebruany, Alex Malinin, Fei-Hua Qiu, X.-C. Xu, Charles Kunsch, Robert Scott, for the ALPS Study Group

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2009

Language:

english

File:

PDF, 272 KB

english, 2009

22

Stability validation of paraformaldehyde-fixed samples for the assessment of the platelet PECAM-1, P-selectin, and PAR-1 thrombin receptor by flow cytometry

Oliver D. Atar, Christian Eisert, Ilya Pokov, Victor L. Serebruany

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2010

Language:

english

File:

PDF, 177 KB

english, 2010

23

Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke

Victor Serebruany, Yanti Sani, Donald Lynch, Alex Schevchuck, Stan Svetlov, Alan Fong, Lionel Thevathasan, Dan Hanley

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2012

Language:

english

File:

PDF, 208 KB

english, 2012

24

The action of dipyridamole to prevent thrombosis: Practical implications for the treatment and prevention of stroke

Christopher D. Booze, Victor L. Serebruany

Journal:

Current Treatment Options in Cardiovascular Medicine

Year:

2006

Language:

english

File:

PDF, 272 KB

english, 2006

25

Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129 314 patients

Victor L. Serebruany, Alex I. Malinin, James J. Ferguson, Javad Vahabi, Dan Atar, Charles H. Hennekens

Journal:

Fundamental & Clinical Pharmacology

Year:

2008

Language:

english

File:

PDF, 287 KB

english, 2008

26

Antiplatelet ‘resistance’ and ‘non-responders’: what do these terms really mean?

Victor L. Serebruany, Christian Eisert, Dan Atar, James J. Ferguson

Journal:

Fundamental & Clinical Pharmacology

Year:

2009

Language:

english

File:

PDF, 77 KB

english, 2009

27

Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens?

Victor L. Serebruany

Journal:

Fundamental & Clinical Pharmacology

Year:

2009

Language:

english

File:

PDF, 78 KB

english, 2009

28

Survival in Acute Myocardial Infarction Induced by Coronary Ligation: Prognostic Relevanceof Certain Hemostatic Factors During the Occlusion Phase

Victor L. Serebruany, Scott R. Solomon, Andrew R. Shustov, William R. Herzog, Paul A. Gurbel

Journal:

Journal of Thrombosis and Thrombolysis

Year:

1998

Language:

english

File:

PDF, 151 KB

english, 1998

29

Crossreactivity of Human versus Swine Platelet Surface Antigens Is Similar for Glycoproteins Ib and IIIa, but Not for the Glycoprotein IIb/IIIa Complex

Victor L. Serebruany, Jose V. Ordonez, Vladimir V. Yurovsky, Paul A. Gurbell

Journal:

Journal of Thrombosis and Thrombolysis

Year:

1998

Language:

english

File:

PDF, 213 KB

english, 1998

30

Aspirin in Patients with Coronary Artery Disease: Is it Simply Irresistible?

Girish V. Nair, Christopher J. Davis, Marcus E. McKenzie, David R. Lowry, Victor L. Serebruany

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2001

Language:

english

File:

PDF, 109 KB

english, 2001

31

Usefulness of Combining Necrosis and Platelet Markers in Triaging Patients Presenting with Chest Pain to the Emergency Department

Victor L. Serebruany, Douglas J. Levine, Girish V. Nair, Andrew F. Meister, Paul A. Gurbel

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2001

Language:

english

File:

PDF, 95 KB

english, 2001

32

Soluble P-selectin Is Not a Surrogate Marker for Platelet P-selectin: Evidence from a Multicenter Chest Pain Study Group

Paul A. Gurbel, Dean J. Kereiakes, Victor L. Serebruany

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2000

Language:

english

File:

PDF, 114 KB

english, 2000

33

Moderate Alcohol Consumption is Associated with Decreased Platelet Activity in Patients Presenting with Acute Myocardial Infarction

Victor L. Serebruany, David R. Lowry, Sergei Y. Fuzailov, Douglas J. Levine, Christopher M. O'Connor, Paul A. Gurbel

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2000

Language:

english

File:

PDF, 90 KB

english, 2000

34

Effect of Coronary Thrombolysis on the Plasma Concentration of Osteonectin (SPARC, BM40) in Patients with Acute Myocardial Infarction

Victor L. Serebruany, Dan Atar, Selva R. Murugesan, Scott Jerome, Husam Semaan, Paul A. Gurbel

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2000

Language:

english

File:

PDF, 87 KB

english, 2000

35

The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease

Serebruany, Victor L., Kogushi, Motoji, Dastros-Pitei, Daniela, Flather, Marcus, Bhatt, Deepak L.

Journal:

Thrombosis and Haemostasis

Year:

2009

File:

PDF, 101 KB

2009

36

Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure

Karen E. Joynt, Wendy A. Gattis, Vic Hasselblad, Sergey Y. Fuzaylov, Victor L. Serebruany, Paul A. Gurbel, Laura H. Gaulden, G.Michael Felker, David J. Whellan, Christopher M. O'Connor

Journal:

The American Journal of Cardiology

Year:

2004

Language:

english

File:

PDF, 139 KB

english, 2004

37

Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials

Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Alex I. Malinin, Jeffrey S. Baggish, Deepak L. Bhatt, Eric J. Topol

Journal:

The American Journal of Cardiology

Year:

2005

Language:

english

File:

PDF, 120 KB

english, 2005

38

Effect of Statins on Platelet PAR-1 Thrombin Receptor in Patients With the Metabolic Syndrome (From the PAR-1 Inhibition by Statins [PARIS] Study)

Victor L. Serebruany, Michael Miller, Alex N. Pokov, Alex I. Malinin, David R. Lowry, Jean-Francois Tanguay, Charles H. Hennekens

Journal:

The American Journal of Cardiology

Year:

2006

Language:

english

File:

PDF, 107 KB

english, 2006

39

Dose of Aspirin and Bleeding Risks

Victor Serebruany

Journal:

The American Journal of Cardiology

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

40

Assessment of Bleeding Events in Clinical Trials—Proposal of a New Classification

Victor L. Serebruany, Dan Atar

Journal:

The American Journal of Cardiology

Year:

2007

Language:

english

File:

PDF, 56 KB

english, 2007

41

The “Clopidogrel Resistance” Trap

Victor L. Serebruany

Journal:

The American Journal of Cardiology

Year:

2007

Language:

english

File:

PDF, 67 KB

english, 2007

42

Excess Rates of Nonfatal Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel (Preventing Clinical Events or Chasing Enzymatic Ghosts?)

Victor L. Serebruany

Journal:

The American Journal of Cardiology

Year:

2008

Language:

english

File:

PDF, 57 KB

english, 2008

43

Controlled Rosuvastatin Multinational Trial in Heart Failure (The Positive Negative Trial)

Victor L. Serebruany

Journal:

The American Journal of Cardiology

Year:

2008

Language:

english

File:

PDF, 44 KB

english, 2008

44

Mortality in the TRITON Trial: Update from the FDA Prasugrel Action Package

Victor L. Serebruany

Journal:

The American Journal of Cardiology

Year:

2010

Language:

english

File:

PDF, 204 KB

english, 2010

45

Timing of thienopyridine loading and outcomes in the TRITON trial: the FDA Prasugrel Action Package outlook

Victor L. Serebruany

Journal:

Cardiovascular Revascularization Medicine

Year:

2011

Language:

english

File:

PDF, 220 KB

english, 2011

46

Magnitude and time course of platelet inhibition with Aggrenox® and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial

Victor L. Serebruany, Alex I. Malinin, David C. Sane, Bernd Jilma, Aviv Takserman, Dan Atar, Charles H. Hennekens

Journal:

European Journal of Pharmacology

Year:

2004

Language:

english

File:

PDF, 329 KB

english, 2004

47

QT dynamicity, microvolt T-wave alternans, and heart rate variability during 24-hour ambulatory electrocardiogram monitoring in the healthy newborn of first to fourth day of life

Leonid Makarov, Vera Komoliatova, Svetlana Zevald, George Schmidt, Аlexander Muller, Victor Serebruany

Journal:

Journal of Electrocardiology

Year:

2010

Language:

english

File:

PDF, 492 KB

english, 2010

48

Relation of soluble and platelet p-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy

Paul A Gurbel, Christopher M O’Connor, Margaret R Dalesandro, Victor L Serebruany

Journal:

The American Journal of Cardiology

Year:

2001

Language:

english

File:

PDF, 315 KB

english, 2001

49

Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease

Victor L Serebruany, Christopher M O’Connor, Paul A Gurbel

Journal:

The American Journal of Cardiology

Year:

2001

Language:

english

File:

PDF, 82 KB

english, 2001

50

Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation

Paul A Gurbel, Alex I Malinin, Kevin P Callahan, Victor L Serebruany, Christopher M O’Connor

Journal:

The American Journal of Cardiology

Year:

2002

Language:

english

File:

PDF, 392 KB

english, 2002